Search results
Helmy Eltoukhy. Helmy Eltoukhy is an American scientist and a businessperson who co-founded startups Avantome and Guardant Health. He is best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. His startups were acquired by Illumina in 2008.
- Co-Founder & CEO, Guardant Health, Co-Founder & CEO, Avantome
- Abbas El Gamal
- An integrated system for de novo DNA sequencing
Helmy is an entrepreneur and pioneer in the biotech industry. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies.
Liked by Helmy Eltoukhy. Location: Redwood City · 500+ connections on LinkedIn. View Helmy Eltoukhy’s profile on LinkedIn, a professional community of 1 billion members.
- 500+
- 2.8K
- Redwood City, California, United States
Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company’s Co-Chief Executive Officer since August 2021. Prior to founding Guardant, Dr. Eltoukhy held various positions at Illumina, Inc., or Illumina, from August 2008 to December 2012, including Senior Director of ...
Mar 6, 2017 · Helmy Eltoukhy is bringing Guardant360 to this year's WIRED Health conference in London. Join hundreds of healthcare, pharmaceutical and technology influencers and leaders at the fourth annual ...
Feb 14, 2021 · Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. Helmy is an entrepreneur and pioneer in the biotech industry. Helmy was named to Fortune’s 40 under 40 in 2017 and the San Francisco Business Times 40 under 40 in 2019, and was one of Time Magazine’s 50 Most ...
Helmy Eltoukhy is the chairman and co-CEO of the leading precision oncology company Guardant Health, which he co-founded in 2012 with Dr. AmirAli Talasaz. In 2007, Eltoukhy co-founded Avantome to commercialize semiconductor sequencing which was acquired by Illumina. While at Illumina, Eltoukhy served as senior director of Advanced Technology ...
